NCPA on new funding deal: Missed opportunity
Congress fumbled a chance to rein in big insurance and PBMs and save taxpayers billions, says NCPA.
Congress fumbled a chance to rein in big insurance and PBMs and save taxpayers billions, says NCPA.
CRN calls for a science-driven FDA strategy, highlighting extensive research backing dietary supplements.
PQA Health Equity Technical Expert Panel recommendations inform measure testing, use in quality programs, and risk adjustment models.
Company no longer anticipates closing previously announced sale to Nexus Capital Management.
Holiday 2024 retail sales face a 3% decline compared to last year despite Black Friday and Cyber Monday boosts.
The continuing resolution to fund the government failed a House vote, 235 to 174.
Clark designed two new basketballs for the Inspire Series – the Tribute and the Dreamer.
Aetna expands app functionality to better connect with Spanish-speaking members
DOJ’s intervention follows the complaint originally filed by Baron & Budd in 2019.
Barnes brings extensive health care management experience to the company.
CRN cautions that misinterpretation of the recommendations as broadly advising against supplementation could lead to the dismissal of other health benefits associated with these essential nutrients.
Aims to drive progress against acute challenges facing children and youth.
But Congress must ignore big insurance and the PBM lobby’s last-ditch effort to scuttle reforms and pass the continuing resolution.
NACDS is hailing PBM reforms contained in the 118th Congress’ culminating legislative package, and is urging the U.S. House of Representatives and U.S. Senate to advance this continuing resolution to President Biden’s desk for signature.
Erlotinib tablets are a kinase inhibitor indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC).
Walmart is testing body cameras for store employees to enhance worker safety amid concerns about harassment and aggressive customer behavior.